<- Back to digest

JOA - 2026-11-12 - Journal Article

Patient Profile and Cause-Specific Lifetime Revision Risk of Primary Total Knee Arthroplasty: An Australian Orthopaedic Association National Joint Replacement Registry Study.

Rele S, Zhou Y, MBiostat CH, Smith PN, Stevens JM

database studyLOE IIn = N not explicitly stated; all primary TKA for OA in AOANJRR 2000–2020 (national registry, likely >500,000 procedures)Up to 20 years of registry data (2000–2020); lifetime risk modeled using actuarial methods incorporating life expectancy.

Topics

arthroplasty
PMID: 43020157DOI: 10.1016/j.arth.2026.11.041View on PubMed ->

Key Takeaway

Lifetime revision risk after primary TKA peaks at 39.0% in patients aged 46–50 years, with young men carrying the highest risk at 41.7% in that cohort.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study used the AOANJRR to calculate cause-specific lifetime revision risk for primary TKA stratified by age band, sex, BMI, and ASA class, addressing the limitation of traditional Kaplan-Meier survival estimates that ignore competing mortality risk. Lifetime revision risk was 39.0% (95% CI 38.3–39.8) in the 46–50 age group, declining monotonically with age to 0% in the 96–100 group. Infection carried the highest lifetime revision risk across all age groups; morbid obesity elevated risk through age 80, and ASA class 4 elevated risk through age 65.

Key Limitation

The analysis does not account for secular trends in implant design, surgical technique, or patient selection over the 20-year study window, meaning lifetime risk estimates derived from early-registry-era revisions may not reflect outcomes for patients implanted with contemporary implants.

Original Abstract

BACKGROUND

Traditional estimates of implant survival reported by joint registries neglect to account for a person's remaining life expectancy after arthroplasty. This study aimed to estimate lifetime revision risk for primary total knee arthroplasty (TKA) across different patient profiles using a large, national joint replacement registry.

METHODS

All patients undergoing primary TKA for osteoarthritis from the Australian Orthopaedic Association National Joint Replacement Registry between January 1, 2000, and December 31, 2020, were included. Patients were organized into 5-year age bands at the time of TKA, and the cumulative lifetime revision risk was calculated, stratified by patient sex, body mass index, American Society of Anesthesiology scores, and causes of revision.

RESULTS

The highest lifetime revision rate was observed in the youngest, 46- to 50-year-old age group (39.0%, 95% confidence interval (CI), 38.3 to 39.8), decreasing to 0% in the 96- to 100-year-old group. Men were associated with higher lifetime revision risk from the 46- to 50-year old group (41.7%, 95% CI, 40.4 to 43.0; women: 37.0%, 95% CI, 36.2 to 37.9). Morbid obesity was associated with higher lifetime revision risk until 80 years of age (76 to 80 years: 5.2%, 95% CI, 3.6 to 6.8). American Society of Anesthesiology class 4 was associated with the highest lifetime revision risk until age 65 years (61 to 65: 12.2%, 95% CI, 9.3 to 15.2). At all ages, infection had the highest lifetime revision risk.

CONCLUSION

Lifetime revision risk provides an easier-to-understand metric for the risk of revision for patients. This study shows lifetime revision risk is highest among young men.